Aeglea BioTherapeutics, Inc.
SEC Filing List
AGLE CIK: 0001636282
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Spyre Therapeutics, Inc. | Workiva Inc. Wdesk FA01 /fa | 10/05/2026 | |
| 4 | Statement of changes in beneficial owner... | King-jones Heidy | Spyre Therapeutics, Inc. | 10/02/2026 | |
| 4 | Statement of changes in beneficial owner... | Burrows Scott L | Spyre Therapeutics, Inc. | 10/02/2026 | |
| 4 | Statement of changes in beneficial owner... | Turtle Cameron | Spyre Therapeutics, Inc. | 10/02/2026 | |
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 10/01/2026 | ||
| SCHEDULE 13G | Toppan Merrill/FA | 10/01/2026 | |||
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 10/01/2026 | ||
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 09/30/2026 | ||
| 8-K | Current report filing | Spyre Therapeutics, Inc. | 09/08/2026 | ||
| 4 | Statement of changes in beneficial owner... | Burrows Scott L | Spyre Therapeutics, Inc. | 09/03/2026 | |
| No record found. | |||||
| Load More | |||||
